Myxoid dermatofibrosarcoma protuberans: A rare variant analyzed in a series of 23 cases

American Journal of Surgical Pathology

Volumn 31, Issue 9, 2007, Pages 1371-1377

  Reimann, Julie D R ^a   Fletcher, Christopher D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dermatofibrosarcoma protuberans; Myxoid; Sarcoma; Skin; Soft tissue

Indexed keywords

CD34 ANTIGEN; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDICAL RECORD REVIEW; TUMOR LOCALIZATION; TUMOR VOLUME;

ACTINS; ADULT; AGED; ANTIGENS, CD34; CELL PROLIFERATION; CHILD; DERMATOFIBROSARCOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MITOSIS; NEOPLASM INVASIVENESS; S100 PROTEINS; SKIN NEOPLASMS; STROMAL CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548266304     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802ff7e7     Document Type: Article

References (12)

1. Fiore M, Miceli R, Mussi C, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23:7669-7675.
2. Frierson HF, Cooper PH. Myxoid variant of dermatofibrosarcoma protuberans. Am J Surg Pathol. 1983;7:445-450.
3. Greco A, Fusetti L, Villa R, et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene. 1998;17:1313-1319.
4. Grouls V. Dermatofibrosarcoma protuberans: a variant myxoid. Pathologe. 1984;5:226-230.
5. Gu W, Ogose A, Kawashima H, et al. Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change. J Clin Pathol. 2005;58:984-986.
6. Haycox CL, Odland PB, Olbricht SM, et al. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997;37:438-444.
7. Hess KA, Hanke CW, Estes NC, et al. Chemosurgical reports: myxoid dermatofibrosarcoma protuberans. J Dermatol Surg Oncol. 1985;11:268-271.
8. McArthur GA, Demetri GD, van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B2225. J Clin Oncol. 2005;23:866-873.
9. Mendenhall WM, Zlotecki RA, Scarborough MT. Dermatofibrosarcoma protuberans. Cancer. 2004;101:2503-2508.
10. Mertens F, Fletcher CD, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408-415.
11. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140:1-12.
12. Zamecnik M, Michal M. Myxoid variant of dermatofibrosarcoma protuberans with fibrosarcomatous areas. Zentralbl Pathol. 1993;139:373-376.